BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34126807)

  • 21. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol.
    Timmermans AJ; de Gooijer CJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Head Neck; 2015 Oct; 37(10):1495-503. PubMed ID: 24891221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery.
    Cheraghlou S; Kuo P; Mehra S; Yarbrough WG; Judson BL
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):497-504. PubMed ID: 29292665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    Dyckhoff G; Plinkert PK; Ramroth H
    BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
    PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
    Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
    Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
    Varghese BT; Sebastian P; Mathew A
    Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
    Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
    Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
    Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
    Forastiere AA; Zhang Q; Weber RS; Maor MH; Goepfert H; Pajak TF; Morrison W; Glisson B; Trotti A; Ridge JA; Thorstad W; Wagner H; Ensley JF; Cooper JS
    J Clin Oncol; 2013 Mar; 31(7):845-52. PubMed ID: 23182993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
    Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
    Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.
    Posner MR; Norris CM; Wirth LJ; Shin DM; Cullen KJ; Winquist EW; Blajman CR; Mickiewicz EA; Frenette GP; Plinar LF; Cohen RB; Steinbrenner LM; Freue JM; Gorbunova VA; Tjulandin SA; Raez LE; Adkins DR; Tishler RB; Roessner MR; Haddad RI;
    Ann Oncol; 2009 May; 20(5):921-7. PubMed ID: 19179556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage.
    Koss SL; Russell MD; Leem TH; Schiff BA; Smith RV
    Laryngoscope; 2014 Feb; 124(2):421-8. PubMed ID: 24323309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors for survival after salvage total laryngectomy following radiotherapy or chemoradiation failure: a 10-year retrospective longitudinal study in eastern Denmark.
    Wulff NB; Andersen E; Kristensen CA; Sørensen CH; Charabi B; Homøe P
    Clin Otolaryngol; 2017 Apr; 42(2):336-346. PubMed ID: 27537427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifications in the treatment of advanced laryngeal cancer throughout the last 30 years.
    García Lorenzo J; Montoro Martínez V; Rigo Quera A; Codina Aroca A; López Vilas M; Quer Agustí M; León Vintró X
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3449-3455. PubMed ID: 28625009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision making in advanced larynx cancer: An evidenced based review.
    Eskander A; Blakaj DM; Dziegielewski PT
    Oral Oncol; 2018 Nov; 86():195-199. PubMed ID: 30409301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx who received concurrent chemoradiation therapy with carboplatin (CBDCA) - AUC 1.5 vs AUC 2.0.
    Furusaka T; Matsuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 Nov; 132(11):1215-23. PubMed ID: 23025385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.